Black Diamond Therapeutics, Inc. (BDTX)
Biotechnology · Healthcare · $96M
Intrinsic Value (Consensus)
$4.00
Current Price
$1.68
Margin of Safety
+138.1%
138.1% Below Intrinsic Value
Value: $4
Price: $2
Valuation Model Estimates
Current Price: $1.68
DCF (Discounted Cash Flow)
$2.09
Graham Number
$4.15
Earnings Power Value
$1.95
Relative Value (P/E)
$7.80
Dividend Discount Model
Not applicable
—
Consensus Value
$4.00
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
63
Profitability
22/25
Strength
15/25
Valuation
22/25
Growth
4/25
Financial Health Signals
High volatility — Beta of 3.24 means 2x+ market swings
High free cash flow yield (26.1%) — generating lots of cash relative to price
Key Financials
- EPS (TTM)
- $0.39
- EPS (Forward)
- $0.41
- Book Value
- $1.96
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- 19.9%
- Debt/Equity
- —
- Revenue Growth
- N/A
- Earnings Growth
- 5.0%
- Dividend Yield
- N/A
- Beta
- 3.24
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-21
Source: Yahoo Finance